PPARA and type 2 diabetes mellitus: PPARs, therefore, represent valuable therapeutic targets and PPAR agonists have for many years represented a promising approach for the treatment of type 2 diabetes and associated metabolic diseases, including obesity, hypertension, and dyslipidemia11.